SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 51.11-2.1%Nov 13 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: enervestor who wrote (824)3/15/2000 3:19:00 PM
From: Mike McFarland  Read Replies (1) of 52153
 
<to retain anything remotely close to the
valuations they are now being accorded>

Yeah, pretty easy to post that sort of message
now with biotech taking it in the shorts, were
you saying that a couple weeks ago, when, for
example, many genomics-oriented companies were
trading 50% higher than where they are now?

I got a kick out of this: A fund manager was
quoted in the SeattleTimes this morning as
saying he was in there selling biotech yesterday,
during the rout. Now why wasn't that goofball
selling a week ago?

It is a good thing that the value DOW stocks are
moving up today, when biotech runs up again in
a week or two that will mean there is more money
out there to pile in.

I'll put my 100% biotech portfolio against anybody
with a 100% not-biotech portfolio for the next six
months. Anybody up for the challenge? Anyone?
Buehler?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext